Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4Venous Thromboembolism 2Thrombocythemia, Essential 1Testicular Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Hemorrhage 1Fallopian Tube Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Breast Neoplasms 1

Interventions

Genetic Testing 2Secretin 1RAD51C protein, human 1Physical Examination 1Observation 1Naproxen 1Mesalamine 1Liquid Biopsy 1Hematologic Tests 1Genetic Counseling 1G-T mismatch-binding protein 1Colonoscopy 1Capsule Endoscopy 1CA-19-9 Antigen 1Blood Specimen Collection 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms, Hereditary Nonpolyposis × Aspirin × Clear all
NCT05411718 2026-06-01

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

M.D. Anderson Cancer Center

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡